Selected article for: "mild group and moderate group"
Author: Yongyu Liu; Lijun Bi; Yu Chen; Yaguo Wang; Joy Fleming; Yanhong Yu; Ye Gu; Chang Liu; Lichao Fan; Xiaodan Wang; Moxin Cheng
Title: Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity
  • Document date: 2020_3_16
    • ID: ffm5fww3_19
    Snippet: With respect to disease severity, the percentage of severe/critical cases with MTB coinfection was significantly higher than that in the mild/moderate group (78% vs 22%; p = 0.0049; Figure 1B ). Seven of the 9 severe/critical cases were IGRA+ve indicating MTB co-infection, and of these, 4 of the 5 cases that developed ARDS were IGRA+ve. By comparison, 21 of 27 cases (78%) in Group 1 (mild/moderate cases) were IGRA-ve and had no history of TB dise.....
    Document: With respect to disease severity, the percentage of severe/critical cases with MTB coinfection was significantly higher than that in the mild/moderate group (78% vs 22%; p = 0.0049; Figure 1B ). Seven of the 9 severe/critical cases were IGRA+ve indicating MTB co-infection, and of these, 4 of the 5 cases that developed ARDS were IGRA+ve. By comparison, 21 of 27 cases (78%) in Group 1 (mild/moderate cases) were IGRA-ve and had no history of TB disease. This data infers that coinfection of SARS-CoV-2 with MTB tends to lead to the development of more severe or critical COVID-19 symptoms.

    Search related documents:
    Co phrase search for related documents
    • ARDS develop and severity disease: 1, 2, 3, 4
    • co infection and mild moderate group: 1
    • co infection and MTB co infection: 1, 2, 3, 4, 5, 6, 7
    • co infection and SARS MTB: 1
    • co infection and severity disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • co infection and TB disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • co infection and TB disease history: 1
    • critical severe symptom and MTB coinfection: 1
    • critical severe symptom and severe critical case: 1
    • critical severe symptom development and MTB coinfection: 1
    • mild moderate case and severe critical case: 1, 2, 3, 4, 5, 6
    • mild moderate case and severity disease: 1, 2, 3, 4
    • mild moderate group and MTB co infection: 1
    • mild moderate group and severity disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
    • mild moderate group and TB disease: 1
    • MTB co infection and SARS MTB: 1
    • MTB co infection and severity disease: 1, 2, 3
    • MTB co infection and TB disease: 1, 2, 3
    • MTB coinfection and SARS MTB: 1